Hypotension Associated With Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity.

Abstract

Intravitreal bevacizumab therapy in preterm infants for retinopathy of prematurity (ROP) can be associated with hypotension. We report twin preterm infants who developed hypotension within 1 day after intravitreal bevacizumab therapy for ROP. Before receiving the medication, their clinical statuses were stable and similar. The dose, procedure, and… (More)
DOI: 10.1542/peds.2015-2005

Topics

3 Figures and Tables

Slides referencing similar topics